Wealthfront’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
MG
WBG
PVH
HF
Wealthfront's XPH Position: Q3 2015 in Review
Wealthfront sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2015, closing a stake of 98 shares — an estimated $6K sold.
Wealthfront first reported a position in XPH in Q2 2014 and held it in 2 quarters. The position peaked at $6K in Q2 2015. 77 funds tracked by Wall St. Rank hold XPH as of Q3 2015.
- Wealthfront reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
- Wealthfront sold 98 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2015, an estimated $6K.
- Wealthfront first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2014 and held it in 2 quarters.
- Wealthfront's State Street SPDR S&P Pharmaceuticals ETF position peaked at $6K in Q2 2015.
- 77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2015.
Based on Wealthfront's 13F filing for Q3 2015, filed 18 Nov 2015.